Manuscripts
Showing 1554 manuscripts.
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial
Citation
Sean S Brummel, James A McIntyre, Friday Saidi, Karin L Kingman, Avy Violari, Nahida Chakhtoura, Dingase Dula, David E Shapiro, Vidya Mave, Mary Glenn Fowler, Lee Fairlie, Judith S Currier, Gerhard Theron, Moreen Kamateeka, Tsungai Chipato, Benjamin H Chi, Lynda Stranix-Chibanda, Teacler Nematadzira, Dhayendre Moodley, Debika Bhattacharya, Risa M Hoffman, Amita Gupta, Konstantia Nadia Angelidou, Anne Coletti, IMPAACT PROMISE 1077BF/FF Team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clinical Trials. 2018. 19: 209-224. PMID: 30890061Year
2018
Journal
HIV Clinical Trials
Study
1077BF, 1077FF
Defining Study Outcomes That Better Reflect Individual Response to Treatment
Citation
Konstantia Angelidou, Jane Lindsey, Avy Violary, Moderndran Archary, Linda Barlow, Brian Claggett, Michael Hughes, Lee-Jen Wei, IMPAACT P1060 Study Team, Paul Palumbo. Defining Study Outcomes That Better Reflect Individual Response to Treatment. Pediatric Infectious Disease Journal. 2018. 37: 258-262. PMID: 29189677Year
2018
Journal
Pediatric Infectious Disease Journal
Study
P1060
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Citation
Angela C Colbers, Alwin D R Huitema, Paolo Denti, Kelly E Dooley, Edmund Capparelli, Brookie M Best, Tim R Cressey, Rick Greupink, Frans G M Russel, Mark Mirochnick, David M Burger, Stein Schalkwijk, Rob Ter Heine. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women. Clinical Pharmacokinetics. 2018. 57: 1421-1433. PMID: 29520730Year
2018
Journal
Clinical Pharmacokinetics
Study
P1026S
H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration
Citation
Christen E. Salyer, Kelly M. Richardson, Adriana Weinberg, Sharon Nachman, Lisa M. Frenkel, Thor A. Wagner, Hannah C. Huang. H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration. Journal of Acquired Immune Deficiency Syndromes. 2017. 14: 7. PMID: 28193244Year
2017
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1086
Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection
Citation
Paige L. Williams, Ann Chahroudi , James M. Oleske , Shirley Traite , Rana Chakraborty, Murli U. Purswani , Mark J. Abzug , IMPAACT P1074 Study Team, Andres F. Camacho-Gonzalez , Miriam C. Chernoff. Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection. Journal of Pediatric Infectious Disease Society. 2017. 6: e22-e29. PMID: 27440505Year
2017
Journal
Journal of Pediatric Infectious Disease Society
Study
P1074
Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa
Citation
SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team, MJ Levin, JC Lindsey. Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa. AIDS. 2017. 2: 49-59. PMID: 27662551Year
2017
Journal
AIDS
Study
P1072
Pharmacokinetics of Darunavir/Ritonavir with Etravirine both twice daily in HIV-infected adolescents and young adults
Citation
Andrew Wiznia, Rohan Hazra, Patrick Jean-Philippe, Bobbie Graham, Amy Gonzalez, Paula Britto, Vincent Carey, Courtney Fletcher, Edward Acosta for the IMPAACT P1058A team, Tim Cressey, Ram Yogev. Pharmacokinetics of Darunavir/Ritonavir with Etravirine both twice daily in HIV-infected adolescents and young adults. Journal of the Pediatric Infectious Diseases Society. 2017. 6: 294-296. PMID: 27103489Year
2017
Journal
Journal of the Pediatric Infectious Diseases Society
Study
P1058A
Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.
Citation
Grace Montepiedra, William Meyer, Hans Spiegel, William Borkowsky, Mark Abzug, Brookie Best, Marilyn Crain, Peggy Borum, Bobbie Graham, Patty Anthony, Katie Shin, George Siberry for the P1063 study team, Ann Melvin, Lisa Aaron. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.. Pediaric Infectious Disease Journal. 2017. 36: 53-60. PMID: 27749649Year
2017
Journal
Pediaric Infectious Disease Journal
Study
P1063
Breast Milk and In Utero Transmission of HIV-1 Select for Envelope Variants with Unique Molecular Signatures
Citation
Edwin Sobrera, Thomas Wilkinson, Katherine Semrau, Chipepo Kankasa, Nicholas Webb, Benhur Lee, Donald Thea, Louise Kuhn, James Mullins, Grace Aldrovandi, Kyle Nakamura, Laura Heath. Breast Milk and In Utero Transmission of HIV-1 Select for Envelope Variants with Unique Molecular Signatures. Retrovirology. 2017. 14: 6. PMID: 28122636Year
2017
Journal
Retrovirology
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041
Citation
George McSherry, Mark Cotton, Patrick Jean-Philippe, Avy Violari, Raziya Bobat, Sharon Nachman, Lynne Mofenson, Shabir Madhi, Charles Mitchell, Bret Zeldow, Soyeon Kim. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. International Journal of Tuberculosis and Lung Disease. 2017. 21: 38-45. PMID: 28157463Year
2017
Journal
International Journal of Tuberculosis and Lung Disease
Study
P1041